The level of 10,650-10,660 is likely to act as a strong barrier for the index as the 50-day moving average is placed in this region. Stocks in news: Unichem Labs, Sunil Agro Foods, IFCI, Nava Bharat Ventures, Sun Pharmaceutical and NMDC.

Indian shares may open lower on Tuesday, tracking mixed cues from Asian markets. The SGX Nifty Index Future indicates that Nifty may open lower by 54 points around the level of 10,593.   

Despite all the push by government, ETFs are preferred by institutional investors. Read on to find how AUM of ETFs have grown for individual and institutional investors.

The stocks most likely to witness significant movement on the bourses on November 27 are HEG, Sun Pharma, Lupin, Suzlon Energy and Yes Bank.

Alembic Pharma’s joint venture, Aleor Dermaceuticals has received USFDA approval for Lidocaine Ointment USP. Shares of the company were up by almost 2 per cent intraday.

The company has received a fresh order from the state government of Himachal Pradesh allotting the Jangi-Thopan-Powari (780 MW) project on BOOT basis.

Godrej Fund Management and Godrej Properties have entered into a joint venture agreement with Hero Cycles to develop a prime office development on Golf Course Road, Gurgaon. Godrej Fund Management is the real estate private equity arm of the Godrej Group, and Godrej Properties Limited is one of India's leading real estate developers.

Pharma major Lupin received approval from the USFDA for two important drugs namely - Clomipramine Hydrochloride Capsules and Potassium Chloride for oral solution USP. 

The shares of Sun Pharma Advanced Research Company (SPARC) gained 8 per cent in Monday's morning session as the company announced the positive results of its pivotal bioequivalence study for a cancer drug.

SEBI, in mutual funds categorization, has created a separate category for mutual funds which are specifically dedicated to an individual’s financial goals such as child education and retirement. These MFs are known as solution-based mutual funds. But is it worth investing in them? Let’s find out.